8/23/2011 10:35:33 AM
AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics, Inc. (“Mirna”) announced today that it has closed a $1.5 million equity financing round. The round adds to the significant funding the Company received through two substantial awards from Texas-based initiatives to further the State’s life sciences efforts and cancer research, respectively. In 2009, Mirna received a $5 million award from the Texas Emerging Technology Fund, which was followed last year by a $10.3 million commercialization award from the Cancer Prevention & Research Institute of Texas (CPRIT).
comments powered by